Fixed Price IPO | ₹7 Cr | Listed at BSE SME | Mon, Apr 30, 2018 - Thu, May 3, 2018
Indo US Bio-Tech IPO is a fixed price issue of ₹7.29 crores. The issue is entirely a fresh issue of 0.14 crore shares of ₹7.29 crore.
Indo US Bio-Tech IPO bidding started from Apr 30, 2018 and ended on May 3, 2018. The shares got listed on BSE SME on May 11, 2018.
Indo US Bio-Tech IPO price is ₹51 per share. The lot size for an application is 2,000. The minimum amount of investment required by an individual investor (retail) is ₹1,02,000 (2000 shares) (based on upper price). The minimum lot size for investment in HNI is 2 lots (4,000 shares), amounting to ₹2,04,000.
Swastika Investmart Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Beeline Broking Ltd..
Refer to Indo US Bio-Tech IPO RHP for detailed Information.
IPO Open
Mon, Apr 30, 2018
IPO Close
Thu, May 3, 2018
Issue Price
₹51 per share
Market Cap (Pre-IPO)
₹24.76 Cr
| IPO Date | 30 Apr to 3 May, 2018 |
| Listed on | Fri, May 11, 2018 |
| Face Value | ₹10 per share |
| Issue Price | ₹51 per share |
| Lot Size | 2,000 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Fixed Price IPO |
| Listing At | BSE SME |
| Total Issue Size | 14,30,000 shares (agg. up to ₹7 Cr) |
| Reserved for Market Maker | 74,000 shares Beeline Broking Ltd. (agg. up to ₹0.3774 Cr) |
| Fresh Issue (Ex Market Maker) | 13,56,000 shares (agg. up to ₹7 Cr) |
| Net Offered to Public | 13,56,000 shares (agg. up to ₹7 Cr) |
| Share Holding Pre Issue | 34,24,392 shares |
| Share Holding Post Issue | 48,54,392 shares |
| BSE Script Code | 541304 INDOUS |
| ISIN | INE250Z01010 |
Indo US Bio-Tech IPO comprises a total issue size of 14,30,000 shares. The net offer to the public is 13,56,000 shares, after excluding 74,000 shares allotted on a firm basis. Of the Net offer 6,78,000 (50.00%) allocated to NII 6,78,000 (50.00%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue |
|---|---|---|---|
| NII (HNI) Shares Offered | 6,78,000 | 50.00% | 47.41% |
| Retail Shares Offered | 6,78,000 | 50.00% | 47.41% |
| Firm Reservations | |||
| Market Maker Shares Offered | 74,000 | 5.17% | |
| Total Shares Offered | 14,30,000 | 100.00% | 100.00% |
Investors can bid for a minimum of 2,000 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2,000 | ₹1,02,000 |
| Retail (Max) | 1 | 2,000 | ₹1,02,000 |
| HNI (Min) | 2 | 4,000 | ₹2,04,000 |
Incorporated in 2004, Gujarat based Indo US Bio-Tech Limited is engaged in the business of breeding products, processing and marketing of high performing open-pollinated and hybrid agricultural seed varieties & (seed testing, soil & water testing ). The company has its own laboratory for seed testing at Junagadh.
The company started In-House Research and Development (R&D) unit at Modasa, District - Sabarkantha (Gujarat) for research activities to produce better and different varieties of seeds. On September 23, 2011, it got the recognition up to March 31, 2014, for In-House R&D from Government of India, Ministry of Science and Technology, Department of Scientific and Industrial Research Technology Bhavan, New Delhi (DSIR).
In the initial stage, the company was engaged in producing different varieties of oilseeds and pulses seeds, later on, it also added vegetable, spices and cereals seeds to its basket. In the year 2014, it shifted its R&D unit Gandhinagar to carry on its research activities.
As on January 31, 2018, Indo US Bio-Tech has 45 Employees in various departments.
| Period Ended |
|---|
| Amount in ₹ Crore |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Incremental Working Capital | 5.04 |
| 2 | General Corporate Purpose | 1.80 |
The Indo US BioTech IPO is subscribed 19.74 times on May 3, 2018 5:00:00 PM (Day 3). The public issue subscribed 19.87 times in the retail category, [.] times in the QIB category, and 19.52 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| NII* | 19.52 | 6,78,000 | 1,32,32,000 |
| Retail | 19.87 | 6,78,000 | 1,34,70,000 |
| Total | 19.74 | 13,56,000 | 2,67,66,000 |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Payment to Merchant Banker including fees and reimbursements of Market Making Fees, selling commissions, brokerages, payment to other intermediaries such as Legal Advisors, Registrars, Bankers etc and other out of pocket expenses. | 0.38 |
| 2 | Printing & Stationery and Postage Expenses | 0.02 |
| 3 | Marketing and Advertisement Expenses | 0.02 |
| 4 | Regulatory fees and other expenses | 0.03 |
| 5 | Other Miscellaneous expenses | 0.02 |
| Price Details | BSE SME |
|---|---|
| Final Issue Price | ₹51.00 |
| Open | ₹55.05 |
| Low | ₹55.05 |
| High | ₹57.80 |
| Last Trade | ₹57.80 |
Lead Manager Reports
Indo US Bio-Tech IPO is a SME IPO of 14,30,000 equity shares of the face value of ₹10 aggregating up to ₹7 Crores. The issue is priced at ₹51 per share. The minimum order quantity is 2000.
The IPO opens on Mon, Apr 30, 2018, and closes on Thu, May 3, 2018.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in Indo US Bio-Tech IPO using UPI as a payment gateway. Zerodha customers can apply in Indo US Bio-Tech IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Indo US Bio-Tech IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Indo US Bio-Tech IPO opens on Mon, Apr 30, 2018 and closes on Thu, May 3, 2018.
Indo US Bio-Tech IPO lot size is 2000, and the minimum amount required for application is ₹1,02,000.
You can apply in Indo US Bio-Tech IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Indo US Bio-Tech IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Indo US Bio-Tech IPO allotment status.
The Indo US Bio-Tech IPO listing date is on Fri, May 11, 2018.
